209 related articles for article (PubMed ID: 34439311)
1. The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma Patients.
Paolino G; Huber V; Camerini S; Casella M; Macone A; Bertuccini L; Iosi F; Moliterni E; Cecchetti S; Ruspantini I; Chiarotti F; Vergani E; Lalli L; Raggi C; Di Biase A; Calvieri S; Mercuri SR; Lugini L; Federici C
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439311
[TBL] [Abstract][Full Text] [Related]
2. Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors.
Federici C; Shahaj E; Cecchetti S; Camerini S; Casella M; Iessi E; Camisaschi C; Paolino G; Calvieri S; Ferro S; Cova A; Squarcina P; Bertuccini L; Iosi F; Huber V; Lugini L
Front Immunol; 2020; 11():262. PubMed ID: 32231660
[TBL] [Abstract][Full Text] [Related]
3. Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients.
Vetsika EK; Sharma P; Samaras I; Markou A; Georgoulias V; Whiteside TL; Kotsakis A
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922569
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.
Daniotti M; Vallacchi V; Rivoltini L; Patuzzo R; Santinami M; Arienti F; Cutolo G; Pierotti MA; Parmiani G; Rodolfo M
Int J Cancer; 2007 Jun; 120(11):2439-44. PubMed ID: 17315191
[TBL] [Abstract][Full Text] [Related]
5. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
6. Variation in human erythrocyte membrane unsaturated Fatty acids: correlation with cardiovascular disease.
Sepulveda JL; Tanhehco YC; Frey M; Guo L; Cropcho LJ; Gibson KM; Blair HC
Arch Pathol Lab Med; 2010 Jan; 134(1):73-80. PubMed ID: 20073608
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker.
Stoitchkov K; Letellier S; Garnier JP; Bousquet B; Tsankov N; Morel P; Ghanem G; Le Bricon T
Melanoma Res; 2003 Dec; 13(6):587-93. PubMed ID: 14646622
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients.
Bustos MA; Gross R; Rahimzadeh N; Cole H; Tran LT; Tran KD; Takeshima L; Stern SL; O'Day S; Hoon DSB
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202891
[TBL] [Abstract][Full Text] [Related]
10. The Lipid Composition of Serum-Derived Small Extracellular Vesicles in Participants of a Lung Cancer Screening Study.
Smolarz M; Kurczyk A; Jelonek K; Żyła J; Mielańczyk Ł; Sitkiewicz M; Pietrowska M; Polańska J; Rzyman W; Widłak P
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298629
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.
Kiniwa Y; Nakamura K; Mikoshiba A; Ashida A; Akiyama Y; Morimoto A; Okuyama R
BMC Cancer; 2021 Mar; 21(1):287. PubMed ID: 33731038
[TBL] [Abstract][Full Text] [Related]
12. Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients.
Schneegans S; Lück L; Besler K; Bluhm L; Stadler JC; Staub J; Greinert R; Volkmer B; Kubista M; Gebhardt C; Sartori A; Irwin D; Serkkola E; Af Hällström T; Lianidou E; Sprenger-Haussels M; Hussong M; Mohr P; Schneider SW; Shaffer J; Pantel K; Wikman H
Mol Oncol; 2020 May; 14(5):1001-1015. PubMed ID: 32246814
[TBL] [Abstract][Full Text] [Related]
13. Signaling of Tumor-Derived sEV Impacts Melanoma Progression.
Zebrowska A; Widlak P; Whiteside T; Pietrowska M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709086
[TBL] [Abstract][Full Text] [Related]
14. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
15. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
16. High plasma proteasome levels are detected in patients with metastatic malignant melanoma.
Stoebner PE; Lavabre-Bertrand T; Henry L; Guiraud I; Carillo S; Dandurand M; Joujoux JM; Bureau JP; Meunier L
Br J Dermatol; 2005 May; 152(5):948-53. PubMed ID: 15888151
[TBL] [Abstract][Full Text] [Related]
17. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.
Mian S; Ugurel S; Parkinson E; Schlenzka I; Dryden I; Lancashire L; Ball G; Creaser C; Rees R; Schadendorf D
J Clin Oncol; 2005 Aug; 23(22):5088-93. PubMed ID: 16051955
[TBL] [Abstract][Full Text] [Related]
18. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.
Hrustincova A; Krejcik Z; Kundrat D; Szikszai K; Belickova M; Pecherkova P; Klema J; Vesela J; Hruba M; Cermak J; Hrdinova T; Krijt M; Valka J; Jonasova A; Merkerova MD
Cells; 2020 Mar; 9(4):. PubMed ID: 32224889
[TBL] [Abstract][Full Text] [Related]
19. Circulating miRNAs in Small Extracellular Vesicles Secreted by a Human Melanoma Xenograft in Mouse Brains.
Guglielmi L; Nardella M; Musa C; Cifola I; Porru M; Cardinali B; Iannetti I; Di Pietro C; Bolasco G; Palmieri V; Vilardo L; Panini N; Bonaventura F; Papi M; Scavizzi F; Raspa M; Leonetti C; Falcone G; Felsani A; D'Agnano I
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575666
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive proteomics profiling identifies NRP1 as a novel identity marker of human bone marrow mesenchymal stromal cell-derived small extracellular vesicles.
Munshi A; Mehic J; Creskey M; Gobin J; Gao J; Rigg E; Muradia G; Luebbert CC; Westwood C; Stalker A; Allan DS; Johnston MJW; Cyr T; Rosu-Myles M; Lavoie JR
Stem Cell Res Ther; 2019 Dec; 10(1):401. PubMed ID: 31852509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]